Erratum to: Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior: hiPSC-MVs Transmit RNAs and Proteins to Heart Cells (STEM CELLS, (2015), 33, 9, (2748-2761), 10.1002/stem.2078);Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior

Stem Cells

Volumn 33, Issue 9, 2015, Pages 2748-2761

  Bobis Wozowicz, Sylwia ^a   Kmiotek, Katarzyna ^a   Sekula, Malgorzata ^a   Kedracka Krok, Sylwia ^a   Kamycka, Elzbieta ^a   Adamiak, Marta ^a   Jankowska, Urszula ^a   Madetko Talowska, Anna ^b   Sarna, Michal ^a   Bik Multanowski, Miroslaw ^c   Kolcz, Jacek ^a   Boruczkowski, Dariusz ^d   Madeja, Zbigniew ^a   Dawn, Buddhadeb ^e   Zuba Surma, Ewa K ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Polish American Hospital   (Poland)

^d Polish Stem Cell Bank   (Poland)

^e UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Cell signaling; Induced pluripotent stem cells; Microvesicles; Paracrine activity; Tissue regeneration

Indexed keywords

MESSENGER RNA; MICRORNA; TRANSCRIPTOME; SERUM-FREE MEDIUM;

ARTICLE; CELL CULTURE; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MEMBRANE MICROPARTICLE; MESENCHYMAL STROMA CELL; PARENT; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEOMICS; REGENERATIVE MEDICINE; SOMATIC CELL; TARGET CELL; TISSUE REGENERATION; TISSUE REPAIR; CARDIAC MUSCLE CELL; DRUG EFFECTS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; SERUM-FREE MEDIUM;

CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCYTES, CARDIAC; RNA, MESSENGER;

EID: 84940467274     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2838     Document Type: Erratum

References (53)

1. Camussi G, Deregibus MC, Bruno S, et al., Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78: 838-848.
2. Rustom A, Saffrich R, Markovic I, et al., Nanotubular highways for intercellular organelle transport. Science 2004; 303: 1007-1010.
3. Ratajczak J, Wysoczynski M, Hayek F, et al., Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495.
4. Quesenberry PJ, Goldberg LR, Aliotta JM, et al., Cellular Phenotype and Extracellular Vesicles: Basic and Clinical Considerations. Stem Cells Dev 2014; 23: 1429-1436.
5. Alvarez-Erviti L, Seow Y, Yin H, et al., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011; 29: 341-345.
6. Cossetti C, Iraci N, Mercer TR, et al., Extracellular vesicles from neural stem cells transfer IFN-γ via IFNGR1 to activate STAT1 signaling in target cells. Mol Cell 2014; 56: 193-204.
7. Sims PJ, Wiedmer T, Esmon CT, et al., Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-17057.
8. Sluijter JPG, Verhage V, Deddens JC, et al., Microvesicles and exosomes for intracardiac communication. Cardiovasc Res 2014; 102: 302-311.
9. Hulsmans M, Holvoet P,. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013; 100: 7-18.
10. Filkova M, Jungel A, Gay RE, et al., MicroRNAs in rheumatoid arthritis: Potential role in diagnosis and therapy. Biodrugs 2012; 26: 131-141.
11. Rood IM, Deegens JKJ, Merchant ML, et al., Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 2010; 78: 810-816.
12. Wang Y, Chen L-M, Liu M-L,. Microvesicles and diabetic complications-Novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacol Sin 2014; 35: 433-443.
13. Russo I, Bubacco L, Greggio E,. Exosomes-associated neurodegeneration and progression of Parkinson's disease. Am J Neurodegener Dis 2012; 1: 217-225.
14. Jorfi S, Inal JM,. The role of microvesicles in cancer progression and drug resistance. Biochem Soc Trans 2013; 41: 293-298.
15. Ohno S, Ishikawa A, Kuroda M,. Roles of exosomes and microvesicles in disease pathogenesis. Adv Drug Deliv Rev 2013; 65: 398-401.
16. Camussi G, Deregibus MC, Cantaluppi V,. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 2013; 41: 283-287.
17. Ranghino A, Cantaluppi V, Grange C, et al., Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol 2012; 25: 75-85.
18. Cantaluppi V, Biancone L, Figliolini F, et al., Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant 2012; 21: 1305-1320.
19. Cantaluppi V, Gatti S, Medica D, et al., Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 2012; 82: 412-447.
20. Gatti S, Bruno S, Deregibus MC, et al., Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011; 26: 1474-1483.
21. Lee C, Mitsialis SA, Aslam M, et al., Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012; 126: 2601-2611.
22. Raisi A, Azizi S, Delirezh N, et al., The mesenchymal stem cell-derivedmicrovesicles enhance sciatic nerve regeneration in rat: A novel approach in peripheral nerve cell therapy. J Trauma Acute Care Surg 2014; 76: 991-999.
23. Zhu YG, Feng XM, Abbott J, et al., Human mesenchymal stem cells microvesicles for treatment of Escherichia coli endotoxin- induced acute lung injury in mice. Stem Cells 2014; 32: 116-125.
24. Ratajczak J, Miekus K, Kucia M, et al., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847-856.
25. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
26. Takahashi K, Tanabe K, Ohnuki M, et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
27. Yu J, Vodyanik MA, Smuga-Otto K, et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
28. Petsa A, Gargani S, Felesakis A, et al., Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. Vitr Cell Dev Biol 2009; 45: 573-576.
29. Qian L, Berry EC, Fu J, et al., Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro. Nat Protoc 2013; 8: 1204-1215.
30. Crescitelli R, Lässer C, Szabó TG, et al., Distinct RNA profiles in subpopulations of extracellular vesicles: Apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2013; 2: 20677.
31. Witwer KW, Buzás EI, Bemis LT, et al., Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013; 2: 20360.
32. Qian Q, Qian H, Zhang X, et al., 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev 2012; 21: 67-75.
33. Lois C, Hong EJ, Pease S, et al., Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872.
34. Barde I, Salmon P, Trono D,. Production and titration of lentiviral vectors. Curr Protoc Neurosci 2010; 53: 4.21.1-4.21.23.
35. Yuan A, Farber EL, Rapoport AL, et al., Transfer of microRNAs by embryonic stem cell microvesicles. Plos One 2009; 4: e4722.
36. Vlachos IS, Kostoulas N, Vergoulis T, et al., DIANA miRPath v.2.0: Investigating the combinatorial effect of microRNAs in pathways. Nucl Acid Res 2012; 40: W498-W504.
37. Ebben JD, Zorniak M, Clark PA, et al., Introduction to induced pluripotent stem cells: Advancing the potential for personalized medicine. World Neurosurg 2011; 76: 270-275.
38. Nishimori M, Yakushiji H, Mori M, et al., Tumorigenesis in cells derived from induced pluripotent stem cells. Hum Cell 2014; 27: 29-35.
39. Hong KU, Guo Y, Li QH, et al., c-kit+ cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. Plos One 2014; 9: e96725.
40. Otsuru S, Gordon PL, Shimono K, et al., Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 2012; 120: 1933-1941.
41. Matsa E, Sallam K, Wu JC,. Cardiac stem cell biology: Glimpse of the past, present, and future. Circ Res 2014; 114: 21-27.
42. Lipchina I, Studer L, Betel D,. The expanding role of miR-302-367 in pluripotency and reprogramming. Cell Cycle 2012; 11: 1517-1523.
43. Sengupta S, Nie J, Wagner RJ, et al., MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 2009; 27: 1524-1528.
44. Del Conde I, Shrimpton CN, Thiagarajan P, et al., Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-1611.
45. Parolini I, Federici C, Raggi C, et al., Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284: 34211-34222.
46. Katsman D, Stackpole EJ, Domin DR, et al., Embryonic stem cell-derived microvesicles induce gene expression changes in Müller cells of the retina. Plos One 2012; 7: e50417.
47. Saadeldin IM, Kim SJ, Choi YB, et al., Improvement of cloned embryos development by co-culturing with parthenotes: A possible role of exosomes/microvesicles for embryos paracrine communication. Cell Reprogram 2014; 16: 223-234.
48. Meckes DG, Raab-Traub N,. Microvesicles and viral infection. J Virol 2011; 85: 12844-12854.
49. Barteneva NS, Maltsev N, Vorobjev IA,. Microvesicles and intercellular communication in the context of parasitism. Front Cell Infect Microbiol 2013; 3: 49.
50. Fevrier B, Vilette D, Archer F, et al., Cells release prions in association with exosomes. Proc Natl Acad Sci USA 2004; 101: 9683-9688.
51. Lee Y, Andaloussi S El, Wood MJA,. Exosomes and microvesicles: Extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012; 21: R125-R134.
52. Wahlgren J, Karlson TDL, Brisslert M, et al., Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucl Acid Res 2012; 40: 3130.
53. Rouhani F, Kumasaka N, Brito MC, et al., Genetic background drives transcriptional variation in human induced pluripotent stem cells. Plos Genet 2014; 10: e1004432.